2023-06-07 14:49:28
(Information sent by the signatory company)
– Breaking boundaries in breast cancer screening: Densitas® and ScreenPoint Medical set out to improve patient outcomes
HALIFAX, NS, June 7, 2023 /PRNewswire/ — Densitas® Inc., a global provider of Artificial Intelligence solutions for digital mammography and breast screening, today announced a strategic partnership with ScreenPoint Medical, a developer of innovative breast imaging solutions. The companies will work together to increase the reach of their industry-leading AI solutions, transforming care delivery for mammography providers and patients alike.
High-quality images are essential for accurate detection of breast cancer, yet up to 50% of mammograms do not meet image quality standards, with poor positioning accounting for 80% of these cases. Through this strategic partnership, Densitas® and ScreenPoint will offer their innovative AI solutions to address these key issues related to poor image quality and positioning, with the goal of improving the accuracy of breast cancer detection and the results of the patients.
“Pragmatic and scalable solutions for precision breast health are needed to improve the quality of mammography and breast cancer diagnosis, both at the individual and population health levels,” said Mo Abdolell, CEO of Densitas. “We are excited to partner with ScreenPoint in our shared vision of applying precision breast imaging to every mammogram taken at every screening to properly manage patients through their journey along the screening, diagnostic, treatment pathways and prevention of breast cancer.
Densitas intelliMammo™ is an advanced mammography quality platform that supports clinical care teams to improve image quality, operational efficiency, compliance with the FDA and American College of Mammography EQUIP Quality Standards Act. Radiology, and clinical confidence built on the foundation of best-in-class AI solutions.
ScreenPoint’s Transpara® uses deep learning to analyze mammograms to improve accuracy to support early detection of breast cancer. Transpara has been shown to reduce mammography reading time for radiologists, building capacity to improve accuracy and productivity in a medical specialty experiencing extraordinary levels of burnout.
“Detecting breast cancer in its early stages is crucial for effective treatment,” said Mark Koeniguer, CEO of ScreenPoint Medical. “We are delighted to partner with Densitas, a company that shares our vision of the importance of high-quality mammography to improve awareness and access to our solutions, driving continuous quality improvement at all stages of cancer detection. from mom.”
Working in tandem, these two best-in-class AI solutions can help improve the accuracy of breast cancer detection, avoid unnecessary procedures due to false-positive results, detect cancer earlier, and reduce costly recalls. This information assists radiologists in their interpretations and enables informed decisions about diagnostic procedures or follow-up screening.
About Densitas®
Densitas® is a world leader in artificial intelligence solutions for breast cancer screening, focused on quality, safety, efficiency and accuracy of breast health. Densitas® intelliMammo™ helps hospitals and diagnostic imaging centers providing mammography services improve efficiency, meet FDA/ACR compliance requirements, and support early detection and treatment of breast cancer. For more information, visit www.densitashealth.com.
About ScreenPoint
ScreenPoint Medical translates cutting-edge machine learning research into technology accessible to radiologists to improve screening workflow, decision confidence, and breast cancer risk assessment. Trusted by radiologists around the world, Transpara has been developed by experts in machine learning and image analysis, and updated with user feedback from renowned breast imaging specialists.
View original content:https://www.prnewswire.com/news-releases/densitas-y-screenpoint-medical-se-disponen-a-mejorar-los-resultados-de-las-pacientes-de-cancer-de-mama-301845090.html
1686151037
#Densitas #ScreenPoint #Medical #Set #Improve #Outcomes #Breast #Cancer #Patients